Lebanon Sci-Tech Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Lebanon Sci-Tech Weekly.

Press releases published on September 4, 2026

6 hours ago

Statement: EdgeMode confirms that the current review process with BlackBerry AIF and BLACK AI Group will be extended for up to six months

Indeterminate GlobeNewswire

6 hours ago

XRP ETF inflows exceed $1.5B as MoneySimpler unveils a user‑ready multi‑factor yield suite to boost returns

Indeterminate GlobeNewswire

6 hours ago

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

6 hours ago

Intellia Therapeutics to Present at Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

6 hours ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

6 hours ago

Iovance Biotherapeutics to Present at Upcoming Conferences

Indeterminate GlobeNewswire

6 hours ago

Rein Therapeutics to Present Late-Breaking Poster at the European Respiratory Society (ERS) 2026 Congress

Indeterminate GlobeNewswire

6 hours ago

Zscaler to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

6 hours ago

Alumis to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

6 hours ago

Nature Methods Publication Reveals Deep Insights into Functional Biology through First-of-its-Kind Quantification of Tau Proteoforms

Indeterminate GlobeNewswire

6 hours ago

Clearmind Medicine Signs Definitive Agreement to Acquire 51% Stake in Wireless Charging Company for Automated Parking and Robotaxis

Indeterminate GlobeNewswire

6 hours ago

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

6 hours ago

Quantum Cyber Invites Qualified Foundries, and Prototype-Development Partners to Apply for Its Quantum-Photonic Antenna Manufacturing Program; Responses Due September 18, 2026

Indeterminate GlobeNewswire

7 hours ago

Zenas BioPharma to Present at Upcoming Healthcare Investor Conferences

Indeterminate GlobeNewswire

7 hours ago

VERAXA Biotech Appoints Raju Willener as Chief Financial Officer

Indeterminate GlobeNewswire

7 hours ago

INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives

Indeterminate GlobeNewswire

7 hours ago

XPPen Debuts Magic Pro 13 at IFA 2026, a Professional All-Scenario Drawing Pad Built to Empower Mobile Creative Workflow

Indeterminate GlobeNewswire

8 hours ago

UAE's Record Investment Inflows Reinforce Global Momentum for AIM Congress 2026

Indeterminate GlobeNewswire

9 hours ago

Bilibili Inc. Announces Proposed Offerings of US$700 Million Convertible Senior Notes, Concurrent Equity Placement and Concurrent Share Repurchases

Indeterminate GlobeNewswire

9 hours ago

Tangram Therapeutics gibt den Übergang zur Patientenkohortenphase in der Phase-I/II-Studie „RESTORE-MASH“ mit TGM-312 sowie die Ernennung von Dr. Sonya Montgomery zur Chief Development Officer bekannt

Indeterminate GlobeNewswire